These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7070974)

  • 1. [Duration of the treatment of tuberculosis in 1981].
    Sors C; Dautzenberg B; Grosset J
    Nouv Presse Med; 1982 Mar; 11(11):831. PubMed ID: 7070974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficiency of interrupted therapy of tuberculosis (experimental study)].
    Drabkina RO; Ginzburg TS
    Antibiotiki; 1972 Jun; 17(6):555-60. PubMed ID: 5045922
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
    Radenbach KL
    Internist (Berl); 1978 Dec; 19(12):672-9. PubMed ID: 370048
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 7. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 9. [New guidelines for pulmonary tuberculosis therapy].
    Steiner A; Medici TC
    Dtsch Med Wochenschr; 1978 Mar; 103(9):372-5. PubMed ID: 631063
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complex hospital treatment of pulmonary tuberculosis].
    Bondarev IM; Batmanov NIa; Shesterina MV; Gavrilenko VS; Tarasova EF
    Sov Med; 1980; (6):79-82. PubMed ID: 6998023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
    Tsukamura M; Yoshii S; Yasuda Y; Saito H
    Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV; Gavrilenko VS; Tarasova EF; Sokolova GV; Tregubov IuG
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Grigaliunas AP; Sushkin AG; Guzeeva SA
    Vrach Delo; 1981 May; (5):21-5. PubMed ID: 7257254
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 15. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
    Kost A; Moskwa Z
    Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A; Gaik A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.